Company Search:
Advanced Search
Sponsored Links
Imprimis Pharmaceuticals Incorporated Company Snapshot
Imprimis Pharmaceuticals Incorporated operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imprimis Pharmaceuticals Incorporated with three other companies in this sector in the United States: Rigel Pharmaceuticals, Inc. (2016 sales of $20.38 million of which 100% was Contract Revenues), TherapeuticsMD Incorporated ($19.36 million of which 100% was Advertising), and ProPhase Labs Inc ($21.01 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Imprimis Pharmaceuticals Incorporated
  Stock Performance Chart for Imprimis Pharmaceuticals Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 1.69
(Figures in U.S. Dollars)
1 Week -2.9%   13 Weeks 7.0%  
4 Weeks 3.7%   52 Weeks -28.1%  
Imprimis Pharmaceuticals Incorporated Key Data:
  Ticker: IMMY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 19,942,000
(Year Ending Jan 2017).
Employees: 3
  Currency: U.S. Dollars Market Cap: 34,079,798
  Fiscal Yr Ends: December Shares Outstanding: 20,165,561
  Share Type: COMMON Closely Held Shares: 1,600,734
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.